InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Schlossberg Mark A, Directeur Juridique. Director active across 2 companies, notably CYTOKINETICS INC. Aggregated, 5 reports have been published. Activity tracked since 19 October 2021. The latest transaction was disclosed on 15 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Schlossberg Mark A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
30,818 shares@ US$7.0333.4% of flowCommon StockSEC:0001061983-22-000077:0
4,631 shares@ US$36.8326.5% of flowCommon StockSEC:0001061983-22-000070:0
3,457 shares@ US$37.6319.7% of flowCommon StockSEC:0001061983-22-000056:0
1,900 shares0Common StockSEC:0001061983-22-000028:0
19,979 shares@ US$7.0320.4% of flowCommon StockSEC:0001061983-21-000241:0
5 of 5 declarations
About Schlossberg Mark A
Mark A. Schlossberg is the Senior VP and General Counsel at Cytokinetics Inc. He oversees the company's legal and regulatory matters, contributing to its compliance and legal strategy.
